The expression of T-cell surface antigens CTLA-4, CD26, and CD28 is modulated by inhibition of dipeptidylpeptidase IV (DPP IV, CD26) activity in murine stress-induced abortions

Cellular Immunology

Volumn 220, Issue 2, 2002, Pages 150-156

  Rüter, Jens ^a   Hoffmann, Torsten ^b   Heiser, Ulrich ^b   Demuth, Hans Ulrich ^b   Arck, Petra C ^a   Klapp, Burghard F ^a   Hildebrandt, Martin ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b PROBIODRUG AG   (Germany)

Author keywords

CD28; CTLA 4; Dipeptidylpeptidase IV (DPP IV, CD26); DPP IV inhibitors; Stress induced abortions

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; ISOLEUCINE CYANOPYRROLIDE; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DENSITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GESTATIONAL AGE; IMMUNOMODULATION; INDUCED ABORTION; MALE; MOUSE; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; STRESS; T LYMPHOCYTE;

ANIMALIA; MURINAE;

EID: 17744406754     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00028-5     Document Type: Article

References (29)

1. Tanaka T., Duke-Cohan J.S., Kameoka J., Yaron A., Lee I., Schlossman S.F., Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. PNAS USA. 91:1994;3082-3086.
2. Dang N., Torimoto Y., Deusch K., Schlossman S., Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:1990;4092-4100.
3. Augustyns K., Bal G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors. Curr. Med. Chem. 6:1999;311-327.
4. Kahne T., Lendeckel U., Wrenger S., Neubert K., Ansorge S., Reinhold D. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int. J. Mol. Med. 4:1999;3-15.
5. Schön E., Mansfeld H., Demuth H., Barth A., Ansorge S. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed. Biochem. Acta. 44:1985;K9-K15.
6. + T cell clones. J. Neuroimmunol. 87:1998;203-209.
7. Reinhold D., Bank U., Buhling F., Lendeckel U., Faust J., Neubert K., Ansorge S. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells. Immunology. 91:1997;354-360.
8. Reinhold D., Bank U., Buhling F., Tager M., Born I., Faust J., Neubert K., Ansorge S. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-β1 (TGF-β1) in stimulated mouse splenocytes and thymocytes. Immunol. Lett. 58:1997;29-35.
9. Steinbrecher A., Reinhold D., Quigley L., Gado A., Tresser N., Izikson L., Born I., Faust J., Neubert K., Martin R., Ansorge S., Brocke S. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-β1 secretion in vivo. J. Immunol. 166:2001;2041-2048.
10. Tanaka S., Murakami T., Horikawa H., Sugiura M., Kawashima K., Sugita T. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int. J. Immunopharmacol. 19:1997;15-24.
11. Korom S., de Meester I., Stadlbauer T., Chandraker A., Schaub M., Sayegh M., Belyaev A., Haemers A., Scharpé S., Kupiec-Weglinski J. Inhibition of CD26/dipeptidylpeptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation. 63:1997;1495-1500.
12. Hildebrandt M., Arck P.C., Kruber S., Demuth H.U., Reutter W., Klapp B.F. Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions. Scand. J. Immunol. 53:2001;449-454.
13. Clark D.A., Banwatt D., Chaouat G. Stress-triggered abortion in mice prevented by alloimmunization. Am. J. Reprod. Immunol. 29:1993;141-147.
14. Arck P.C., Merali F.S., Manuel J., Chaouat G., Clark D.A. Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-α (TNF-α) release as a mechanism triggering resorptions in mice. Am. J. Reprod. Immunol. 33:1995;74-80.
15. Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., Lorsbach R.B., Sharpe A.H. CTLA-4 and T cell activation. Curr. Opin. Immunol. 11:1999;294-300.
16. Wells A.D., Walsh M.C., Bluestone J.A., Turka L.A. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:2001;895-903.
17. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 356:1992;607-609.
18. Arck P.C., Merali F.S., Stanisz A.M., Stead R.H., Chaouat G., Manuel J., Clark D.A. Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol. Reprod. 53:1995;814-819.
19. + T cells as a basis for stress-triggered substance P-mediated abortion in mice. Cell Immunol. 171:1996;226-230.
20. Markert U.R., Arck P.C., McBey B.A., Manuel J., Croy B.A., Marshall J.S., Chaouat G., Clark D.A. Stress triggered abortions are associated with alterations of granulated cells into the decidua. Am. J. Reprod. Immunol. 37:1997;94-100.
21. Arck P.C., Troutt A.B., Clark D.A. Soluble receptors neutralizing TNF-α and IL-1 block stress-triggered murine abortion. Am. J. Reprod. Immunol. 37:1997;262-266.
22. Clark D.A., Chaouat G., Arck P.C., Mittruecker H.W., Levy G.A. Cytokine-dependent abortion in CBA. × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase] J. Immunol. 160:1998;545-549.
23. + TNF-α+ decidual cells via substance P. Am. J. Reprod. Immunol. 45:2001;303-309.
24. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
25. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985-988.
26. Arndt M., Reinhold D., Lendeckel U., Spiess A., Faust J., Neubert K., Ansorge S. Specific inhibitors of dipeptidyl peptidase IV suppress mRNA expression of DP IV/CD26 and cytokines. Adv. Exp. Med. Biol. 477:2000;139-143.
27. Arndt M., Lendeckel U., Spiess A., Faust J., Neubert K., Reinhold D., Ansorge S. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-β(1). Biochem. Biophys. Res. Commun. 274:2000;410-414.
28. Bradshaw J.D., Lu P., Leytze G., Rodgers J., Schieven G.L., Bennett K.L., Linsley P.S., Kurtz S.E. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry. 36:1997;15975-15982.
29. Ohnuma K., Munakata Y., Ishii T., Iwata S., Kobayashi S., Hosono O., Kawasaki H., Dang N.H., Morimoto C. Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs. J. Immunol. 167:2001;6745-6755.